Genetic markers of severe cutaneous adverse reactions
Jae-Woo Jung, Jae-Yeol Kim, In-Won Park, Byoung-Whui Choi, Hye-Ryun Kang
Korean J Intern Med. 2018;33(5):867-875.   Published online 2018 Jun 22     DOI: https://doi.org/10.3904/kjim.2018.126
Citations to this article as recorded by Crossref logo
Personalisierte Medizin in der Allergologie
W. Pfützner, J. Pickert, C. Möbs
Der Hautarzt.2019; 70(1): 5.     CrossRef
Drug reaction with eosinophilia and systemic symptoms syndrome induced by combination of vemurafenib and cobimetinib in melanoma: A series of 11 cases
Barbara Brégeon, Claire Bernier, Nicolas Josselin, Lucie Peuvrel, Marie Le Moigne, Mélanie Saint-Jean, Gaëlle Quéreux
Journal of the American Academy of Dermatology.2019; 80(2): 558.     CrossRef
Analysis of Individual Case Safety Reports of Severe Cutaneous Adverse Reactions in Korea
Min-Gyu Kang, Kyung-Hee Sohn, Dong-Yoon Kang, Han-Ki Park, Min-Suk Yang, Ju-Yeun Lee, Hye-Ryun Kang
Yonsei Medical Journal.2019; 60(2): 208.     CrossRef
Making Rash Decisions in Epilepsy: Evaluating Hypersensitivity Reactions to Anti-seizure Medications
Adriana Bermeo-Ovalle
Epilepsy Currents.2019; 19(2): 96.     CrossRef
The role of pharmacogenomics in adverse drug reactions
Ramón Cacabelos, Natalia Cacabelos, Juan C. Carril
Expert Review of Clinical Pharmacology.2019; 12(5): 407.     CrossRef
Carbonic anhydrase inhibitor–induced Stevens-Johnson syndrome/toxic epidermal necrolysis leads to extensive cutaneous involvement
Sujeong Kim, James Yun, Dong Yoon Kang, Hye-Jung Park, Eun-Jung Jo, Jae-Woo Jung, Hye-Kyung Park, Jung-Won Park, Young-Koo Jee, Hye-Ryun Kang, Jong-Myung Lee
The Journal of Allergy and Clinical Immunology: In Practice.2019;[Epub]     CrossRef